FELECIA LILLY: Open Payments
NPI 1336663608 · CANTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$437 in 22 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $464 · 2025 $437
Food & beverage: $437
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| Inspire Medical Systems, Inc. | 1 | $33 |
| Lundbeck LLC | 2 | $31 |
| Indivior Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $22 |
| Verona Pharma, Inc. | 1 | $21 |
| Alkermes, Inc. | 1 | $18 |
Products named: CAPLYTA, REXULTI, Auvelity, FANAPT, INSPIRE, SUBLOCADE, GVOKE HYPOPEN, Ohtuvayre.
Industry payments across OH — which companies pay providers there.
